Temis aquires i3 Analytics

Temis, which provides semantic content enrichment solutions, has acquired the US-based i3 Analytics, a provider of data analytics and visualisation technologies.

Founded in 2011, i3 Analytics provides Biopharma Navigator, a software-as-a-service platform that charts the biopharma landscape based on life sciences open data. Biopharma Navigator is said to enable life-sciences professionals to work faster, provide critical information to their peers, and make fast and informed clinical, regulatory, and business decisions.

Temis says the acquisition reinforces its commitment and capabilities to serving its customers by strengthening its product range with a complementary SaaS analytics and discovery offering and expanding its know-how with the integration of a team of former NIH engineers. The acquisition will also enable Temis to accelerate its penetration into new application areas in Life Sciences.

'The acquisition of i3 Analytics demonstrates our commitment to the Life Sciences market,' said Eric Brégand, CEO of TEMIS.

'This transaction creates a best-in-class offering for our Life Sciences customers, based on the winning combination of deep computational linguistics expertise and leading-edge data visualisation know-how. And we will be transposing the solution to other verticals where data analytics and information visualisation are also becoming critical.'